Press Releases Choose Year All Items 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Search Press Releases Found 265 Results March 5, 2024 Relmada Therapeutics to Participate in the Leerink Partners Global Biopharma Conference January 4, 2024 Relmada Therapeutics Provides Corporate Update November 8, 2023 Relmada Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results November 3, 2023 Relmada Therapeutics to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 8, 2023 October 11, 2023 Relmada Therapeutics to Present New Preclinical Data on its Psilocybin Program at AASLD The Liver Meeting® 2023 October 9, 2023 Relmada Therapeutics to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit October 6, 2023 Relmada Therapeutics to Present Data from its REL-1017 and Psilocybin Programs at the 36th European College of Neuropsychopharmacology (ECNP) Congress September 20, 2023 Relmada Therapeutics Announces Efficacy and Safety Results from the Phase 3 Long-Term Study of REL-1017 in Major Depressive Disorder August 23, 2023 Relmada Therapeutics Announces Dosing of First Patient in Relight, a Phase 3 Trial of REL-1017 for the Adjunctive Treatment of Major Depressive Disorder August 8, 2023 Relmada Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results «...456789...»
